Operating independently within Sanofi, Opella has resources allocated for research and development, production, and digital ...

PARIS (Reuters) -Sanofi has entered into talks to sell a controlling 50% stake in its consumer health business Opella to U.S.

Sanofi said it entered talks to sell a controlling stake in consumer health business Opella to private-equity firm Clayton ...

The French government is looking at options including taking a state holding in the consumer health business that Sanofi is ...

Sanofi on Friday said it’s in talks with the private equity firm CD&R to sell just over half of its consumer healthcare ...

Sanofi is in talks to sell a 50% controlling stake in its consumer health unit to CD&R. It is set to be one of the biggest deals this year, following similar moves by big pharma peers GSK Plc, ...

Sanofi enters into negotiations with CD&R to sell controlling stake in Opella: Paris Monday, October 14, 2024, 10:00 Hrs [IST] Sanofi announces that the company has entered into n ...

(Reuters) - Private equity firm Clayton Dubilier & Rice (CD&R) is nearing a deal to acquire Sanofi's consumer health unit for ...

The French government is looking at options including state-owned investment bank BPIfrance taking a stake in the consumer ...

Sanofi to sell consumer health unit for $16.4 billion to private equity firm Clayton Dubilier & Rice in upcoming deal ...

Pfizer and GSK in hiving off businesses that sell over-the-counter medicines to focus on more lucrative, but riskier, prescription drugs. Sanofi's negotiations with CD&R show the Paris-based ...

As Sanofi moves forward with talks to potentially sell a 50% stake its consumer health unit Opella, fears of job cuts and ...